Free mRNA Cancer Vaccine Coming to Russia in 2025

Tejal Somvanshi

Photo Source: Сергей Велов (Pexels)

Russia's Ministry of Health has announced the development of an mRNA-based cancer vaccine, scheduled for free distribution to patients beginning in early 2025.

This cancer vaccine employs messenger RNA (mRNA) technology and has the ability to suppress tumour growth and prevent metastases.

Photo Source: Nephron (CC BY-SA 3.0)

Photo Source: Rayne Zaayman-Gallant (CC-BY-NC-ND 4.0)

Researchers are exploring collaboration with the Ivannikov Institute to potentially implement AI solutions that could reduce vaccine customization time.

It is a collaboration between Gamaleya National Research Center for Epidemiology and Microbiology, Hertsen Moscow Oncology Research Institute, and Blokhin Cancer Research Center.

Photo Source: N.N.Blokhin Russian Cancer Research Center (LinkedIn)

Photo Source: NIH Image Gallery (PDM 1.0)

According to WHO data cited in the source material, 2022 saw approximately 20 million new cancer cases and 10 million deaths globally.

The National Cancer Institute says that mRNA vaccines work by directing cells to produce proteins that may stimulate an immune response and target them when present in tumor cells

Photo Source: Asian Development Bank (CC BY-NC 2.0)

Photo Source: WillMcC (CC BY-SA 3.0)

On the global level, organisations such as UK-BioNTech, University of Florida, and collaborations like Moderna-Merck, are working on specific cancer vaccines.

President Vladimir Putin stated in February that they have come very close to the creation of so-called cancer vaccines and immunomodulatory drugs of a new generation.

Photo Source: World Economic Forum (CC BY-NC-SA 2.0)

7,107 Duloxetine Bottles Recalled Over Cancer-Causing Contaminants